SEC Filing Summary: Synaptogenix, Inc. (SNPX)
Business Context and Reporting Period
This Form 8-K was filed by Synaptogenix, Inc. on February 17, 2023, reporting events occurring on February 16, 2023. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in New York, New York. The filing addresses the outcome of a Special Meeting of stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance proceedings and does not contain financial performance data.
Material Changes
The primary event reported is the adjournment of the Special Meeting of stockholders held on February 16, 2023. No business was conducted other than the adjournment. The meeting was originally convened to vote on a proposal detailed in the Definitive Proxy Statement filed on January 9, 2023. The record date for the meeting remains December 20, 2022.
Guidance, Outlook, and Management Commentary
Joshua Silverman, the Company's Chairman and Chair of the Special Meeting, announced that the meeting would reconvene at a date and time to be determined. The filing does not contain financial guidance, risk factors, or commentary on operational outlook beyond the procedural status of the stockholder vote.
Key Facts for Investor Verification
- The Special Meeting of stockholders held on February 16, 2023, was adjourned without a vote on the proposed matter.
- A new date and time for the reconvened meeting have not yet been determined.
- The record date for stockholders eligible to vote remains December 20, 2022.
- The filing contains no financial data; investors should refer to the most recent 10-K or 10-Q for financial metrics.